The Clinical Trial Collaborations (CTC) conference focuses on arguably the most important change in drug development: How we are altering the way we collaborate to drive greater efficiencies in productivity and bring us closer to the patient.

At the 2nd annual CTC event, we present a wide variety of sessions, which demonstrate new ways of collaborating for improved clinical trial outcomes as well as addressing how to strike a better balance in the delivery model for effective drug development.

We are pleased to announce that the 2017 conference opens with Ken Getz, Director of Sponsored Research Programs, Tufts CSDD, on how the Clinical Collaborations Landscape is Changing and its Impact on R&D Operations.

Immediately following this session is a fireside keynote discussion with Dr Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck, who joins Ken in an honest and open discussion on Models for Exquisite Project Delivery with Internal and External Partners.

Also confirmed to keynote is Dr Andy Plump, Director, Chief Medical & Scientific Officer, Takeda  and Dr Steve Cutler, COO and CEO Designate, ICON. We are delighted to welcome back Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly, as co-chair. New to the program, Judith Dunn, VP, Global Head of Clinical Development and Head, Innovation Center, Roche, will lead an interactive session identifying technology needs and solutions.

2017 Keynotes to Date

Clinical Research as a Care Option

We are particularly excited to present a collaborative session on Clinical Research as a Care Option. This section of the 2017 CTC event will make up 25% of the program and for good reason. If we really want to bring patients closer to clinical research, we have to figure out how to collaborate to make clinical trials a care option. Higher rates of clinical trial participation inside a health system produces better patient outcomes, lower cost of care and happier patients. Health systems and patients get access to the latest research and pharma gets access to more patients. This is why we will be dedicating the entire afternoon of April 4 to working through the process of how to make this a reality.

New to the 2017 Conference: Partnering Tool

Also new to the 2017 event is access to a partnering tool and partnering facilities to have small group and one-on-one meetings.

CTC will present insightful ideas and challenges for R&D operations, CROs and site executives to discover new ways of collaborating. The conference is designed for senior level clinical operation executives from large, medium and small pharmas, CROs and sites. Patient advocacy organizations are also encouraged to attend.

We are proud to collaborate on CTC with CenterWatch, the exclusive lead media partner on the event.